Circulating tumor cells and bone marrow micrometastasis.
Sensitive immunocytochemical and molecular assays allow the detection of single circulating tumor cells (CTC) in the peripheral blood and disseminated tumor cells (DTC) in the bone marrow as a common and easily accessible homing organ for cells released by epithelial tumors of various origins. The results obtained thus far have provided direct evidence that tumor cell dissemination starts already early during tumor development and progression. Tumor cells are frequently detected in the blood and bone marrow of cancer patients without clinical or even histopathologic signs of metastasis. The detection of DTC and CTC yields important prognostic information and might help to tailor systemic therapies to the individual needs of a cancer patient. In the present review, we provide a critical review of (a) the current methods used for detection of CTC/DTC and (b) data on the molecular characterization of CTC/DTC with a particular emphasis on tumor dormancy, cancer stem cell theory, and novel targets for biological therapies; and we pinpoint to (c) critical issues that need to be addressed to establish CTC/DTC measurements in clinical practice.
Alix-Panabières
Catherine
C
University Medical Center, Lapeyronie Hospital, Montpellier, France.
Riethdorf
Sabine
S
Pantel
Klaus
K
D001856:Bone Marrow Examination / Q000379:methods; D019046:Bone Marrow Neoplasms / Q000556:secondary*; D006403:Hematologic Tests / Q000379:methods; D006801:Humans; D009369:Neoplasms / Q000473:pathology*; D009360:Neoplastic Cells, Circulating; D011379:Prognosis